[A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy].

Ryota Mukai, Hiroshi Wada, Yoshito Tomimaru, Naoki Hama, Koichi Kawamoto, Shogo Kobayashi, Hidetoshi Eguchi, Koji Umeshita, Yuichiro Doki, Masaki Mori, Hiroaki Nagano

Research output: Contribution to journalArticle

Abstract

We report a case of multiple intrahepatic recurrence of hepatocellular carcinoma( HCC) that was successfully treated with transcatheter arterial chemoembolization( TACE) and sorafenib therapy. A 73-year-old man was diagnosed as having multiple intrahepatic recurrence in segment 2 (S2) and segment 7 (S7) of the liver on abdominal computed tomography (CT) scans 4 years after he underwent liver resection. He was treated with 5 cycles of TACE. Two years and 6 months after the initial TACE, we found that the patient had become refractory to TACE, and therefore, we initiated sorafenib therapy. The response to treatment was stable disease (SD) for 9 months, but the patient's tumor marker levels increased and the tumor gradually increased. Therefore, he underwent additional TACE for the intrahepatic lesions. The patient is still alive with recurrences 4 years and 8 months after the initial recurrence.

Original languageEnglish
Pages (from-to)1813-1815
Number of pages3
JournalUnknown Journal
Volume40
Issue number12
Publication statusPublished - Jan 1 2013

Fingerprint

tumor
Hepatocellular Carcinoma
Recurrence
Survival
lesion
tomography
Liver
Therapeutics
Tumor Biomarkers
Tomography
sorafenib
therapy
Neoplasms
marker

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Mukai, R., Wada, H., Tomimaru, Y., Hama, N., Kawamoto, K., Kobayashi, S., ... Nagano, H. (2013). [A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy]. Unknown Journal, 40(12), 1813-1815.

[A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy]. / Mukai, Ryota; Wada, Hiroshi; Tomimaru, Yoshito; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Eguchi, Hidetoshi; Umeshita, Koji; Doki, Yuichiro; Mori, Masaki; Nagano, Hiroaki.

In: Unknown Journal, Vol. 40, No. 12, 01.01.2013, p. 1813-1815.

Research output: Contribution to journalArticle

Mukai, R, Wada, H, Tomimaru, Y, Hama, N, Kawamoto, K, Kobayashi, S, Eguchi, H, Umeshita, K, Doki, Y, Mori, M & Nagano, H 2013, '[A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy].', Unknown Journal, vol. 40, no. 12, pp. 1813-1815.
Mukai, Ryota ; Wada, Hiroshi ; Tomimaru, Yoshito ; Hama, Naoki ; Kawamoto, Koichi ; Kobayashi, Shogo ; Eguchi, Hidetoshi ; Umeshita, Koji ; Doki, Yuichiro ; Mori, Masaki ; Nagano, Hiroaki. / [A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy]. In: Unknown Journal. 2013 ; Vol. 40, No. 12. pp. 1813-1815.
@article{c519836f189f48428b1f56543998d9bf,
title = "[A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy].",
abstract = "We report a case of multiple intrahepatic recurrence of hepatocellular carcinoma( HCC) that was successfully treated with transcatheter arterial chemoembolization( TACE) and sorafenib therapy. A 73-year-old man was diagnosed as having multiple intrahepatic recurrence in segment 2 (S2) and segment 7 (S7) of the liver on abdominal computed tomography (CT) scans 4 years after he underwent liver resection. He was treated with 5 cycles of TACE. Two years and 6 months after the initial TACE, we found that the patient had become refractory to TACE, and therefore, we initiated sorafenib therapy. The response to treatment was stable disease (SD) for 9 months, but the patient's tumor marker levels increased and the tumor gradually increased. Therefore, he underwent additional TACE for the intrahepatic lesions. The patient is still alive with recurrences 4 years and 8 months after the initial recurrence.",
author = "Ryota Mukai and Hiroshi Wada and Yoshito Tomimaru and Naoki Hama and Koichi Kawamoto and Shogo Kobayashi and Hidetoshi Eguchi and Koji Umeshita and Yuichiro Doki and Masaki Mori and Hiroaki Nagano",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "1813--1815",
journal = "Quaternary International",
issn = "1040-6182",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - [A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy].

AU - Mukai, Ryota

AU - Wada, Hiroshi

AU - Tomimaru, Yoshito

AU - Hama, Naoki

AU - Kawamoto, Koichi

AU - Kobayashi, Shogo

AU - Eguchi, Hidetoshi

AU - Umeshita, Koji

AU - Doki, Yuichiro

AU - Mori, Masaki

AU - Nagano, Hiroaki

PY - 2013/1/1

Y1 - 2013/1/1

N2 - We report a case of multiple intrahepatic recurrence of hepatocellular carcinoma( HCC) that was successfully treated with transcatheter arterial chemoembolization( TACE) and sorafenib therapy. A 73-year-old man was diagnosed as having multiple intrahepatic recurrence in segment 2 (S2) and segment 7 (S7) of the liver on abdominal computed tomography (CT) scans 4 years after he underwent liver resection. He was treated with 5 cycles of TACE. Two years and 6 months after the initial TACE, we found that the patient had become refractory to TACE, and therefore, we initiated sorafenib therapy. The response to treatment was stable disease (SD) for 9 months, but the patient's tumor marker levels increased and the tumor gradually increased. Therefore, he underwent additional TACE for the intrahepatic lesions. The patient is still alive with recurrences 4 years and 8 months after the initial recurrence.

AB - We report a case of multiple intrahepatic recurrence of hepatocellular carcinoma( HCC) that was successfully treated with transcatheter arterial chemoembolization( TACE) and sorafenib therapy. A 73-year-old man was diagnosed as having multiple intrahepatic recurrence in segment 2 (S2) and segment 7 (S7) of the liver on abdominal computed tomography (CT) scans 4 years after he underwent liver resection. He was treated with 5 cycles of TACE. Two years and 6 months after the initial TACE, we found that the patient had become refractory to TACE, and therefore, we initiated sorafenib therapy. The response to treatment was stable disease (SD) for 9 months, but the patient's tumor marker levels increased and the tumor gradually increased. Therefore, he underwent additional TACE for the intrahepatic lesions. The patient is still alive with recurrences 4 years and 8 months after the initial recurrence.

UR - http://www.scopus.com/inward/record.url?scp=84897018649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897018649&partnerID=8YFLogxK

M3 - Article

C2 - 24393931

AN - SCOPUS:84897018649

VL - 40

SP - 1813

EP - 1815

JO - Quaternary International

JF - Quaternary International

SN - 1040-6182

IS - 12

ER -